Long term follow up on IST-3
16 Oct
I read this a few months back and forgot to post something on it. It’s not headline data the way IST 3 was but it’s worth knowing it’s out there. This is the long term (by which they mean 18 … Read More »
I read this a few months back and forgot to post something on it. It’s not headline data the way IST 3 was but it’s worth knowing it’s out there. This is the long term (by which they mean 18 … Read More »
OK so IST-3 is out. It’s a big and important trial so make sure and read it. Stroke lytics get a lot of attention from EM folks, if only because we seem the only ones not convinced of its efficacy. … Read More »
If you’ve read the sprawling behemoth that is my critique of (now not so) recent stroke literature you’ll notice that it ends with a spiel on IST-3 – the big 3000 pt RCT that hopes to settle the question of … Read More »